Clarifying signatures of single-cell paired heavy and light chain BCR repertoire of SARS-CoV-2 infection and vaccination can help expose the nature of COVID-19 and guide therapeutic agent development as well as vaccine design and assessment [7,21]. This evidence concerns the gene BCR and COVID-19.